To Our Valued Customers
At Corning, we are proud of our more than 100-year history supporting life science customers with high quality, innovative solutions. The COVID-19 pandemic has created an unprecedented increase in global demand for our products –as much as 200% to 1000%– that are used in multiple parts of the value chain for diagnostics, treatments, and vaccines.
Our commitment to our customers and the industry has never been stronger, and so our response to the pandemic must also be unprecedented. To that end, we are pleased to announce a greater than $500 million investment in manufacturing capacity expansion between 2020 and 2021 including government co-investments to support domestic manufacturing of critical supply chain components.